Oncology Central

Incidence and prognostic value of recurrent chromosomal abnormalities in elderly patients with multiple myeloma

0

Evaluation of: Avet-Loiseau H, Hulin C, Campion L et al. Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome experience. J. Clin. Oncol. 31(22), 2806–2809 (2013). Chromosomal abnormalities are well-established biomarkers used in the subclassification and risk stratification of multiple myeloma patients. Patients with t(4;14)(p16;q32) and deletion 17p13 are considered to have a poor prognosis, and do not respond to any of the available therapies. However, most studies of chromosomal abnormalities incidence and risk stratification have been performed in patients younger than 66 years of age; therefore we have very limited data on the elderly population.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.